All In Biotech

Drug Trial Radar · NCT01541553

A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp

Last checked: Nov 20, 2026Latest source record: Mar 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 367 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

367

Actual

Start

Mar 2012

Primary completion

Jul 2013

Study completion Jul 2013

Sponsor

Lead sponsor
LEO PharmaIndustry
Sponsor type
Industry
First posted
Mar 1, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this trial is to compare the rate of complete clearance of actinic keratosis (AK) using sequential cryotherapy and field treatment with PEP005 Gel compared to cryotherapy alone.

Conditions

  • Actinic Keratosis

Interventions

  • CryotherapyProcedure

    Cryotherapy of all visible AKs (4-8 lesions, "baseline lesions") in the selected treatment area

  • VehicleDrug

    Field treatment with vehicle gel once daily for 3 consecutive days.

  • Ingenol metabuteDrug

    Field treatment with vehicle gel once daily for 3 consecutive days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete Clearance of AKs at Week 11Time frame: 11 weeks

Locations

35 sites in 1 country. Site status is shown where the registry gives one.

  • Center for Dermatology Clinical Research

    Fremont, California

  • Dermatology Specialists, Inc.

    Oceanside, California

  • Skin Surgery Medical Group, Inc.

    San Diego, California

  • University Clinical Trials, Inc.

    San Diego, California

  • Colorado Medical Research Center, Inc.

    Denver, Colorado

  • About Skin Dermatology and DermSurgery, PC

    Englewood, Colorado

  • The Center for Clincial and Cosmetic Research

    Aventura, Florida

  • Study Protocol, Inc.

    Boynton Beach, Florida

  • North Florida Dermatology Associates, PA

    Jacksonville, Florida

  • University of South Florida, Carol and Frank Morsani Center for Advanced Healthcare

    Tampa, Florida

  • MedaPhase

    Newnan, Georgia

  • Gwinnett Clinical Research Center, Inc.

    Snellville, Georgia

  • Altman Dermatology Associates

    Arlington Heights, Illinois

  • Laser & Skin Surgery Center of Indiana

    Carmel, Indiana

  • The Indiana Clinical Trials Center, PC

    Plainfield, Indiana

  • Great Lakes Research Center

    Bay City, Michigan

  • Henry Ford Medical Centre - New Center One, Department of Dermatology

    Detroit, Michigan

  • Grekin Skin Institute

    Warren, Michigan

  • Minnesota Clinical Study Center

    Fridley, Minnesota

  • Academic Dermatology Associates

    Albuquerque, New Mexico

  • Mount Sinai School of Medicine

    New York, New York

  • Skin Search of Rochester, Inc.

    Rochester, New York

  • Long Island Skin Cancer and Dermatologic Surgery

    Smithtown, New York

  • Oregon Medical Research Center, PC

    Portland, Oregon

  • Oregon Health & Science University, Dept. of Dermatology

    Portland, Oregon

  • Philadelphia Institute of Dermatology

    Fort Washington, Pennsylvania

  • Dermatology Research Associates, Inc.

    Nashville, Tennessee

  • Arlington Research Center, Inc.

    Arlington, Texas

  • Suzanne Bruce and Associates, P.A.

    Houston, Texas

  • Dermatology Clinical Research Center of San Antonio

    San Antonio, Texas

  • Center for Clinical Studies

    Webster, Texas

  • Dermatology Research Center, Inc.

    Salt Lake City, Utah

  • The Education & Research Foundation, Inc.

    Lynchburg, Virginia

  • Virginia Clinical Research, Inc.

    Norfolk, Virginia

  • Premier Clinical Research

    Spokane, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.